Current understanding of AD pathophysiology and impact of amyloid-beta targeted treatments on biomarkers and clinical endpoints.

ABSTRACT:

SUBMITTER: Petersen RC 

PROVIDER: S-EPMC9583953 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature